Oncology & Cancer

A combined approach to treating metastatic melanoma

Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy. Cassian Yee and colleagues describe their approach ...

Oncology & Cancer

New treatment for advanced melanoma shows promise

In a study appearing in the April 19, 2016 issue of JAMA, Antoni Ribas, M.D., Ph.D., of the University of California-Los Angeles, and colleagues examined tumor response and overall survival following administration of the ...

Oncology & Cancer

Non-HIV-related kaposi sarcoma in BRAFi-treated patient

(HealthDay)—In a case report published online Feb. 28 in the Journal of Clinical Pharmacy and Therapeutics, researchers document non-HIV-associated Kaposi sarcoma in a male patient with myasthenia gravis and metastatic ...

Oncology & Cancer

Melanoma therapy tied to cutaneous adverse events

(HealthDay)—Anti-programmed cell death (PD)-1 therapy for metastatic melanoma is associated with the development of immune-related cutaneous events, according to research published in the March issue of the Journal of the ...

Oncology & Cancer

Nivolumab, contact immunotx treats in-transit melanoma

(HealthDay)—Nivolumab in combination with contact immunotherapy can successfully treat in-transit melanoma, according to two case reports published online Dec. 12 in the Journal of Dermatology.

page 10 from 16